Genetic alterations during colorectal-tumor development
- PMID: 2841597
- DOI: 10.1056/NEJM198809013190901
Genetic alterations during colorectal-tumor development
Abstract
Because most colorectal carcinomas appear to arise from adenomas, studies of different stages of colorectal neoplasia may shed light on the genetic alterations involved in tumor progression. We looked for four genetic alterations (ras-gene mutations and allelic deletions of chromosomes 5, 17, and 18) in 172 colorectal-tumor specimens representing various stages of neoplastic development. The specimens consisted of 40 predominantly early-stage adenomas from 7 patients with familial adenomatous polyposis, 40 adenomas (19 without associated foci of carcinoma and 21 with such foci) from 33 patients without familial polyposis, and 92 carcinomas resected from 89 patients. We found that ras-gene mutations occurred in 58 percent of adenomas larger than 1 cm and in 47 percent of carcinomas. However, ras mutations were found in only 9 percent of adenomas under 1 cm in size. Sequences on chromosome 5 that are linked to the gene for familial adenomatous polyposis were not lost in adenomas from the patients with polyposis but were lost in 29 to 35 percent of adenomas and carcinomas, respectively, from other patients. A specific region of chromosome 18 was deleted frequently in carcinomas (73 percent) and in advanced adenomas (47 percent) but only occasionally in earlier-stage adenomas (11 to 13 percent). Chromosome 17p sequences were usually lost only in carcinomas (75 percent). The four molecular alterations accumulated in a fashion that paralleled the clinical progression of tumors. These results are consistent with a model of colorectal tumorigenesis in which the steps required for the development of cancer often involve the mutational activation of an oncogene coupled with the loss of several genes that normally suppress tumorigenesis.
Similar articles
-
High frequency of allelic deletion on chromosome 17p in advanced colorectal cancer.Cancer. 1994 Jan 1;73(1):28-35. doi: 10.1002/1097-0142(19940101)73:1<28::aid-cncr2820730107>3.0.co;2-3. Cancer. 1994. PMID: 8275434
-
Somatic APC and K-ras codon 12 mutations in periampullary adenomas and carcinomas from familial adenomatous polyposis patients.Oncogene. 1995 May 4;10(9):1875-8. Oncogene. 1995. PMID: 7753564
-
Suppressor gene alterations in the colorectal adenoma-carcinoma sequence.J Cell Biochem Suppl. 1992;16G:137-41. doi: 10.1002/jcb.240501124. J Cell Biochem Suppl. 1992. PMID: 1469893 Review.
-
The adenoma-adenocarcinoma sequence in the large bowel: variations on a theme.J Cell Biochem Suppl. 1992;16G:41-6. doi: 10.1002/jcb.240501108. J Cell Biochem Suppl. 1992. PMID: 1335099 Review.
-
Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.Cancer Res. 1992 Jul 15;52(14):3965-71. Cancer Res. 1992. PMID: 1319835
Cited by
-
Identification of a 5-Gene Cuproptosis Signature Predicting the Prognosis for Colon Adenocarcinoma Based on WGCNA.Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241250285. doi: 10.1177/15330338241250285. Technol Cancer Res Treat. 2024. PMID: 38802999 Free PMC article.
-
[Colorectal cancer screening with virtual colonography].Radiologie (Heidelb). 2024 Jun;64(6):471-478. doi: 10.1007/s00117-024-01321-0. Epub 2024 May 13. Radiologie (Heidelb). 2024. PMID: 38739177 German.
-
Modelling esophageal adenocarcinoma and Barrett's esophagus with patient-derived organoids.Front Mol Biosci. 2024 Apr 24;11:1382070. doi: 10.3389/fmolb.2024.1382070. eCollection 2024. Front Mol Biosci. 2024. PMID: 38721276 Free PMC article. Review.
-
Evaluating the utility of ZNF331 promoter methylation as a prognostic and predictive marker in stage III colon cancer: results from CALGB 89803 (Alliance).Epigenetics. 2024 Dec;19(1):2349980. doi: 10.1080/15592294.2024.2349980. Epub 2024 May 8. Epigenetics. 2024. PMID: 38716804 Free PMC article. Clinical Trial.
-
Investigation of Trpa1 and Trpc1 Immunreactivities in Colon Adenocarcinomas.Cancer Manag Res. 2024 Apr 24;16:377-384. doi: 10.2147/CMAR.S447549. eCollection 2024. Cancer Manag Res. 2024. PMID: 38699653 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources